US2023414652A1PendingUtilityA1

Composition and therapy for treatment of gag reflexes

79
Assignee: ORION INNOVATIONS INCPriority: Dec 30, 2019Filed: Sep 11, 2023Published: Dec 28, 2023
Est. expiryDec 30, 2039(~13.4 yrs left)· nominal 20-yr term from priority
Inventors:Robert OlsonDeshka OlsonWayne A. Provost
A61K 33/14A61P 1/00A61K 9/0056A61K 47/12A61K 9/14A61P 43/00A61K 9/20A61K 9/70A61K 9/7007A61K 9/0095A61K 9/145A61P 21/02A61K 31/194A61K 9/006
79
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to compositions and methods for controlling a gag reflex in a patient.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition for controlling a gag reflex in a patient, the composition comprising sodium chloride and a souring agent in a ratio of 3:1 by volume. 
     
     
         2 . The composition of  claim 1 , wherein the composition is a powder form. 
     
     
         3 . The composition of  claim 1 , wherein the composition is a liquid form. 
     
     
         4 . The composition of  claim 1 , wherein the composition is a dissolving film. 
     
     
         5 . The composition of  claim 1 , wherein the composition is an oral disintegrating tablet. 
     
     
         6 . The composition of  claim 1 , wherein the souring agent comprises one or more of citric acid, lemon juice, lemon juice powder, lime juice, lime juice powder, amchur, sour plum, sour plum juice, sour plum juice powder, sumac, tamarind, tamarind powder, vinegar, vinegar powder, umeboshi vinegar, umeboshi vinegar powder, verjuice, verjuice powder. 
     
     
         7 . The composition of  claim 4 , wherein the dissolving film comprises one or more excipients selected from the group consisting of strip-forming polymers, plasticizers, sweetening agents, saliva stimulating agents, flavoring agents, coloring agents, stabilizing agents, and thickening agents. 
     
     
         8 . A method for controlling a gag reflex in a patient, the method comprising:
 providing a composition consisting essentially of sodium chloride and a souring agent in a ratio of 3:1 by volume; and   administering a therapeutic amount of the composition to the patient by contacting a top surface of the patient's tongue with the therapeutic amount of the composition.   
     
     
         9 . The method of  claim 8 , comprising a step for delaying an oral procedure by a delay of less than 20 seconds after administering the therapeutic amount of the composition to the patient. 
     
     
         10 . The method of  claim 8 , comprising a step for commencing an oral procedure within 12 hours after administering the therapeutic amount of the composition to the patient. 
     
     
         11 . The method of  claim 8 , wherein the composition is a powder form. 
     
     
         12 . The method of  claim 8 , wherein the composition is a dissolving film.

Join the waitlist — get patent alerts

Track US2023414652A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.